Law Offices of Howard A. Snyder
15165 Ventura Boulevard, Suite 450  Los Angeles, CA 91403-3373  USA
(818)878-8281  FAX (818)461-1793

Welcome     Attorney     In the News     Notable Cases     Contact Us


Copyright © 2018 Law Offices of Howard Snyder.   All Rights Reserved.



The Law Offices of Howard A. Snyder have years of experience representing hundreds of clients from across the nation against some of the largest pharmaceutical companies in the world. Our firm has the skill, knowledge and resources necessary to hold those responsible for your injuries accountable in a court of law. If you or someone you love has been diagnosed with Tardive Dyskinesia while or after taking Reglan, please Contact Us  immediately or call toll-free (866) 739-8546.

Reglan – FDA Issues Black Box Warning

Reglan, containing the active ingredient metoclopramide, is a medication used to treat intestinal disorders like heartburn, gastroesophageal reflux disease (GERD) and diabetic gastroparesis. Reglan works by causing contractions of the stomach and small intestines in order to force food to pass more quickly through the body. Unfortunately, Reglan has been linked to Tardive Dyskinesia, a devastating and often irreversible condition which leads to involuntary muscle movements including:

• Puckering or pursing of the lips;
• Uncontrollable movement of the tongue, jaw or neck;
• Blinking or bulging of the eyes;
• Involuntary facial expressions;
• Restless Leg Syndrome;
• Uncontrollable hand or finger movements and
• Rapid or shallow breathing

As a result of these links, the United States Food and Drug Administration (FDA) required the manufacturer of Reglan to place a black box warning on the label. A black box warning is the most stringent warning that the FDA can impose. This type of warning means that studies of this drug have revealed a significant risk of serious or even life-threatening adverse effects. According to the FDA, Reglan is only intended for short-term use because of its potential to cause serious side effects. Those most at risk from the use of Reglan include long-term users of the drug, young children and the elderly. Elderly women seem to be particularly at-risk for developing Tardive Dyskinesia.  Unfortunately, Tardive Dyskinesia has no known cure and symptoms often persist even after use of the drug is discontinued. The active ingredient, metoclopramide, is available in several formulations including:

• Reglan Tablets
• Reglan Injections
• Reglan Oral Disintegrating Tablets; and
• Metoclopramide Oral Solution

If you or someone you love has been injured by the drug Reglan, Contact Us or call our toll free number (866) 739-8546.